Showing 1 - 20 results of 56 for search 'Joel S. Parker', query time: 0.05s Refine Results
  1. 1
    Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer.

    Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer. by Aaron R Thorner, Joel S Parker, Katherine A Hoadley, Charles M Perou

    Published 2010-10-01
    Get full text
    Article
  2. 2
    Genetic determinants of the molecular portraits of epithelial cancers

    Genetic determinants of the molecular portraits of epithelial cancers by Youli Xia, Cheng Fan, Katherine A. Hoadley, Joel S. Parker, Charles M. Perou

    Published 2019-12-01
    Get full text
    Article
  3. 3
    An integrated model for predicting KRAS dependency.

    An integrated model for predicting KRAS dependency. by Yihsuan S Tsai, Yogitha S Chareddy, Brandon A Price, Joel S Parker, Chad V Pecot

    Published 2023-05-01
    Get full text
    Article
  4. 4
    Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality

    Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality by Sara R. Selitsky, David Marron, Lisle E. Mose, Joel S. Parker, Dirk P. Dittmer

    Published 2018-10-01
    Get full text
    Article
  5. 5
    Translating transcriptomic findings from cancer model systems to humans through joint dimension reduction

    Translating transcriptomic findings from cancer model systems to humans through joint dimension reduction by Brandon A. Price, J. S. Marron, Lisle E. Mose, Charles M. Perou, Joel S. Parker

    Published 2023-02-01
    Get full text
    Article
  6. 6
    RNA-Sequencing of Umbilical Cord Blood to Investigate Spontaneous Preterm Birth: A Pilot Study

    RNA-Sequencing of Umbilical Cord Blood to Investigate Spontaneous Preterm Birth: A Pilot Study by Neeta L. Vora, Joel S. Parker, Piotr A. Mieckowski, Lisa Smeester, Rebecca C. Fry, Kim A. Boggess

    Published 2019-01-01
    Get full text
    Article
  7. 7
    Mutation of androgen receptor N-terminal phosphorylation site Tyr-267 leads to inhibition of nuclear translocation and DNA binding.

    Mutation of androgen receptor N-terminal phosphorylation site Tyr-267 leads to inhibition of nuclear translocation and DNA binding. by Mehmet Karaca, Yuanbo Liu, Zhentao Zhang, Dinuka De Silva, Joel S Parker, H Shelton Earp, Young E Whang

    Published 2015-01-01
    Get full text
    Article
  8. 8
    Validation of reference genes for whole blood gene expression analysis in cord blood of preterm and full-term neonates and peripheral blood of healthy adults

    Validation of reference genes for whole blood gene expression analysis in cord blood of preterm and full-term neonates and peripheral blood of healthy adults by Kristin Hieronymus, Benjamin Dorschner, Felix Schulze, Neeta L. Vora, Joel S. Parker, Jennifer Lucia Winkler, Angela Rösen-Wolff, Stefan Winkler

    Published 2021-06-01
    Get full text
    Article
  9. 9
    Tn-Seq Analysis Identifies Genes Important for <named-content content-type="genus-species">Yersinia pestis</named-content> Adherence during Primary Pneumonic Plague

    Tn-Seq Analysis Identifies Genes Important for <named-content content-type="genus-species">Yersinia pestis</named-content> Adherence during Primary Pneumonic Plague by Kara R. Eichelberger, Victoria E. Sepúlveda, John Ford, Sara R. Selitsky, Piotr A. Mieczkowski, Joel S. Parker, William E. Goldman

    Published 2020-08-01
    Get full text
    Article
  10. 10
    Spatially Distinct Neutrophil Responses within the Inflammatory Lesions of Pneumonic Plague

    Spatially Distinct Neutrophil Responses within the Inflammatory Lesions of Pneumonic Plague by Nikolas M. Stasulli, Kara R. Eichelberger, Paul A. Price, Roger D. Pechous, Stephanie A. Montgomery, Joel S. Parker, William E. Goldman

    Published 2015-10-01
    Get full text
    Article
  11. 11
    I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms

    I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms by Kin Yau Wong, Cheng Fan, Maki Tanioka, Joel S. Parker, Andrew B. Nobel, Donglin Zeng, Dan-Yu Lin, Charles M. Perou

    Published 2019-03-01
    Get full text
    Article
  12. 12
    Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging

    Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging by William A. Wood, Janakiraman Krishnamurthy, Natalia Mitin, Chad Torrice, Joel S. Parker, Anna C. Snavely, Thomas C. Shea, Jonathan S. Serody, Norman E. Sharpless

    Published 2016-09-01
    Get full text
    Article
  13. 13
    Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibition

    Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibition by Yihsuan S. Tsai, Mark G. Woodcock, Salma H. Azam, Leigh B. Thorne, Krishna L. Kanchi, Joel S. Parker, Benjamin G. Vincent, Chad V. Pecot

    Published 2022-02-01
    Get full text
    Article
  14. 14
    Dynamic changes in lung responses after single and repeated exposures to cigarette smoke in mice.

    Dynamic changes in lung responses after single and repeated exposures to cigarette smoke in mice. by Michelle L Engle, Justine N Monk, Corey M Jania, Jessica R Martin, John C Gomez, Hong Dang, Joel S Parker, Claire M Doerschuk

    Published 2019-01-01
    Get full text
    Article
  15. 15
    Virus expression detection reveals RNA-sequencing contamination in TCGA

    Virus expression detection reveals RNA-sequencing contamination in TCGA by Sara R. Selitsky, David Marron, Daniel Hollern, Lisle E. Mose, Katherine A. Hoadley, Corbin Jones, Joel S. Parker, Dirk P. Dittmer, Charles M. Perou

    Published 2020-01-01
    Get full text
    Article
  16. 16
    Erratum: “FUV Observations of the Inner Coma of 46P/Wirtanen” (2021, PSJ, 2, 8)

    Erratum: “FUV Observations of the Inner Coma of 46P/Wirtanen” (2021, PSJ, 2, 8) by John W. Noonan, Walter M. Harris, Steven Bromley, Davide Farnocchia, Jian-Yang Li, Kathleen E. Mandt, Joel Wm. Parker, Kumar Venkataramani, Dennis Bodewits

    Published 2023-01-01
    Get full text
    Article
  17. 17
    A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer

    A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer by Michael R. Kelly, Kamila Wisniewska, Matthew J. Regner, Michael W. Lewis, Andrea A. Perreault, Eric S. Davis, Douglas H. Phanstiel, Joel S. Parker, Hector L. Franco

    Published 2022-07-01
    Get full text
    Article
  18. 18
    Development and validation of a NanoString BASE47 bladder cancer gene classifier.

    Development and validation of a NanoString BASE47 bladder cancer gene classifier. by Jordan Kardos, Tracy L Rose, Ujjawal Manocha, Sara E Wobker, Jeffrey S Damrauer, Trinity J Bivalaqua, Max Kates, Kristin J Moore, Joel S Parker, William Y Kim

    Published 2020-01-01
    Get full text
    Article
  19. 19
    Prognostic value of B cells in cutaneous melanoma

    Prognostic value of B cells in cutaneous melanoma by Sara R. Selitsky, Lisle E. Mose, Christof C. Smith, Shengjie Chai, Katherine A. Hoadley, Dirk P. Dittmer, Stergios J. Moschos, Joel S. Parker, Benjamin G. Vincent

    Published 2019-05-01
    Get full text
    Article
  20. 20
    Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer

    Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer by Ciara H. O’Flanagan, Emily L. Rossi, Shannon B. McDonell, Xuewen Chen, Yi-Hsuan Tsai, Joel S. Parker, Jerry Usary, Charles M. Perou, Stephen D. Hursting

    Published 2017-07-01
    Get full text
    Article

Search Tools: